发明名称 |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
摘要 |
The present invention relates to compounds of formula I: or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds. |
申请公布号 |
US7683033(B2) |
申请公布日期 |
2010.03.23 |
申请号 |
US20050051977 |
申请日期 |
2005.02.04 |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
COTTRELL KEVIN M.;COURT JOHN J.;DEININGER DAVID D.;FARMER LUC J.;PITLIK JANOS;PERMI ROBERT B. |
分类号 |
A61K38/07;A61K38/00;A61K38/04;A61K38/05;A61K39/42;C07K5/02;C07K5/04;C07K7/02;C07K14/18 |
主分类号 |
A61K38/07 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|